Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study-Reference-Cited by-同舟云学术

Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study

Published:2017-03-22 Issue:15 Volume:38 Page:1119-1127
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Pieske Burkert¹,Maggioni Aldo P.²,Lam Carolyn S.P.³,Pieske-Kraigher Elisabeth⁴,Filippatos Gerasimos⁵,Butler Javed⁶,Ponikowski Piotr⁷,Shah Sanjiv J.⁸,Solomon Scott D.⁹,Scalise Andrea-Viviana¹⁰,Mueller Katharina¹⁰,Roessig Lothar¹⁰,Gheorghiade Mihai¹¹

Affiliation:

1. Charité Universitätsmedizin, Department of Internal Medicine and Cardiology, Charité University Medicine, Augustenburgerplatz 1, 13353 Berlin, Germany, and Department of Internal Medicine Cardiology, German Heart Center Berlin, DZHK (German Center for Cardiovascular Research) and Berlin Institute of Health (BIH)

2. Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Via La Marmora 36, 50121 Firenze, Italy

3. National Heart Centre Singapore and Duke-NUS Graduate Medical School, 5, Hospital Drive, Singapore 169609, Singapore

4. Department of Internal Medicine and Cardiology, Charité University Medicine, Augustenburgerplatz 1, 13353 Berlin, Germany

5. National and Kapodistrian University of Athens, School of Medicine, Attikon University Hospital, Rimini 1, 12462, Athens, Greece

6. Division of Cardiology, Stony Brook University, 101 Nicolls Road, Stony Brook, NY 11794, USA

7. Wroclaw Medical University, 4th Military Hospital, Weigla 5, Wroclaw 50-981, Poland

8. Northwestern University, 676 N. St. Clair St., Suite 600, Chicago, IL 60611, USA

9. Brigham and Women's Hospital, Cardiovascular Division, 75 Francis Street, Boston, MA 02115, USA

10. Bayer AG, Aprather Weg 18, 42113 Wuppertal, Germany

11. Northwestern University Feinberg School of Medicine, 201 East Huron Street Galter 3-150, Chicago, IL 60601, USA

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/38/15/1119/24120294/ehw593.pdf

Reference22 articles.

1. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction;van Heerebeek;Circulation,2012

2. The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction;Greene;J Am Heart Assoc,2013

3. NO-independent regulatory site on soluble guanylate cyclase;Stasch;Nature,2001

4. Recognizing worsening chronic heart failure as an entity and an end point in clinical trials;Butler;JAMA,2014

5. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry;Fonarow;J Am Coll Cardiol,2007

Cited by 279 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart failure with preserved ejection fraction: New challenges and new hopes;La Presse Médicale;2024-03

2. Soluble guanylate cyclase stimulators for heart failure: a network meta-analysis and subgroup analyses of reduced and preserved ejection fraction;The Egyptian Heart Journal;2024-01-24

3. Heart Failure with Preserved Ejection Fraction: The Pathophysiological Mechanisms behind the Clinical Phenotypes and the Therapeutic Approach;International Journal of Molecular Sciences;2024-01-08

4. The Mechanism of Soluble Guanylate Cyclase-Veliciguat for Heart Failure;Advances in Clinical Medicine;2024

5. Titin takes centerstage among cytoskeletal contributions to myocardial passive stiffness;Cytoskeleton;2023-12-29